Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Cytori Therapeutics (CYTX) Shows Strength: Stock Up 13.2%

Cytori Therapeutics, Inc. CYTX was a big mover last session, as its shares rose above 13% on the day. The upside might have been driven by the receipt of patents by the company in Japan and Europe which has expanded its portfolio significantly. This also led to far more shares changing hands than in a normal session. Yesterday’s rally continues the recent uptrend for the company, as the stock is now up over 72% in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cytori Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked biomedical stock is Anika Therapeutics Inc. ANIK with a Zacks Rank #1 (Strong Buy).

Is CYTX going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CYTORI THERAPEU (CYTX): Free Stock Analysis Report
 
ANIKA THERAPEUT (ANIK): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research